Pfizer Inc. (PFE) Stock Research, Analysis & News

Quick Analysis on Pfizer Inc. (PFE) Stock as of July 21, 2018

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Pfizer Inc. (PFE) Stock below)

Pfizer Inc. (PFE) Stock Profile Summary

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. The companys Biopharmaceutical segment offers products in the areas of primary care, specialty care, established products, emerging markets, and oncology customer-focused units. Its principal products include Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Revatio for pulmonary arterial hypertension; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimers disease. This segments products also comprise Celebrex for osteoarthritis and rheumatoid arthritis and acute pain; Zyvox for Gram-positive pathogens; Viagra for erectile dysfunction; Detrol/ Detrol LA for overactive bladder; Sutent for advanced renal cell carcinoma; Xalatan for open-angle glaucoma and ocular hypertension; Genotropin for growth disorders; Vfend, an antifungal agent; Effexor for depressive disorders; Prevnar/Prevnar7 for invasive pneumococcal disease; Enbrel for rheumatoid arthritis; Protonix, proton pump inhibitor for erosive esophagitis; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, which include antibiotics, anti-inflammatories, antiemetics, parasiticides, and vaccines; consumer healthcare products comprising dietary supplements, pain management, respiratory, and topicals/gastro-intestinal products; Nutrition products; and Capsugel products that include gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. It has a strategic alliance with Acacia Living Inc. The company was founded in 1849 and is headquartered in New York, New York.

Pfizer Inc. (PFE) Stock Key Statistics Research and Analysis as of July 21, 2018

Pfizer Inc. (PFE) Stock Competitor Research and Analysis

Merck & Co. Inc. (MRK)Novartis AG (NVS)
Amgen Inc. (AMGN)Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)Sanofi-Aventis (SNY)
AstraZeneca PLC (AZN)

Mutual Funds with Pfizer Inc. (PFE) Stock in its top 10 holdings

FundCategoryPFE Holding Percentage
Alpine Accelerating Dividend InstlLarge Blend2.16%
AB Value ALarge Value3.33%
AB Value AdvisorLarge Value3.33%
American Century Value BLarge Value3.22%
Invesco ExchangeLarge Blend4.01%
American Century Income & Growth CLarge Value1.71%
American Century Equity Income InstlLarge Value3%

ETFs with Pfizer Inc. (PFE) Stock in its top 10 holdings

Stock Research on Pfizer Inc. (PFE)

Latest Market News on Pfizer Inc. (PFE)


Click here to find the latest news on Pfizer Inc. (PFE)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Merck & Co. Inc. (MRK)
Novartis AG (NVS)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
AstraZeneca PLC (AZN)